Healthcare Industry News: dialysis
News Release - October 16, 2012
ZOLL Medical and GS GmbH (corpuls) Form Licensing Agreement to Incorporate ZOLL’s Real CPR Help in corpuls DefibrillatorsBoth Companies Committed to Helping Users Improve CPR Quality with Real Time Feedback
CHELMSFORD, Mass. & KAUFERING, Germany--(Healthcare Sales & Marketing Network)--ZOLL Medical Corporation and GS Elektromedizinische Geraete G. Stemple GmbH, marketing defibrillators under the corpuls brand, announced today that they have concluded a licensing agreement allowing corpuls to incorporate ZOLL’s Real CPR Help® feedback technology into corpuls devices to help their customers improve CPR quality. corpuls customers will be able to receive real-time feedback while providing CPR, helping to ensure performance meets the recommended guidelines for depth, rate, release, and minimal interruptions. In addition, corpuls devices will be able to record CPR performance for post event review and debriefing of rescuers, important capabilities for quality assurance and quality improvements in resuscitation outcomes.
Quality CPR is an important aspect of successful resuscitation, and guidelines-compliant performance and skills have been shown to be difficult to maintain and ensure. The physical demands of providing quality CPR often result in rescuer fatigue and declining performance. ZOLL technology can detect all aspects of performance and provide real-time feedback to rescuers to help them maintain high-quality CPR over a rescue. Real CPR Help from ZOLL, in conjunction with other improvements in resuscitation practices, has been reported to improve resuscitation rates and long-term survival significantly in a number of published and presented studies. Two studies reporting on the use of the technology demonstrated a doubling and a tripling, respectively, of long-term survival*.
Jonathan A. Rennert, President of ZOLL, says, “We are pleased corpuls recognizes the importance of providing real-time CPR feedback to its customers via the superior technology that ZOLL has developed in this field. While we are competitors in some markets, both ZOLL and corpuls share a strong desire to help customers improve their overall resuscitation practices and feel that this common interest outweighs commercial advantages ZOLL would retain by not licensing this technology to other companies in the field of resuscitation.”
“corpuls is recognized for its technology and unique products in many markets and is a highly respected supplier of advanced defibrillation and monitoring devices,” he continued. “Laerdal is also a ZOLL licensee of Real CPR Help and we now welcome corpuls. It is clearly our intention to make this technology available to others when possible and have it become the standard in the industry.”
“We believe that ZOLL’s Real CPR Help technology is the best available means of helping customers improve their CPR quality and practices. Cooperation with ZOLL to incorporate this for our customers made perfect sense,” said Dr. Christian Klimmer, Managing Director of corpuls. “We expect to begin offering this technology to corpuls customers at the beginning of 2013. We are incorporating it into all devices we sell as a standard feature in view of its importance in improving resuscitation. Devices in the market can easily be upgraded with this new feature. We look forward to being able give corpuls’ customers more assistance in improving their CPR and welcome the cooperation with ZOLL.”
About Real CPR Help
Real CPR Help provides real-time depth and rate compression feedback to rescuers as they deliver cardiopulmonary resuscitation (CPR). It coaches rescuers to administer high-quality CPR with auditory and visual real-time feedback, guiding both professional and lay rescuers to the 2010 AHA/ERC Guidelines, which recommend a depth of at least 2 inches (5 cm) and a rate of 100 compressions per minute.
ZOLL introduced Real CPR Help five years before improving CPR quality became the cornerstone of the 2005 AHA/ERC Guidelines. It has been incorporated into virtually all ZOLL defibrillators since 2002—AEDs, BLS and ALS.
About GS Elektromedizinische Geraete G. Stemple GmbH
For more than 30 years, GS Elektromedizinische Geraete G. Stemple GmbH, a successful international family business, has been developing innovative medical devices for the emergency and intensive care medicine and manufacturers. Worldwide professional emergency services rely on the corpuls’ brand of robust and reliable medical products. For more information, visit www.corpuls.com.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 25,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
Copyright © 2012 ZOLL Medical Corporation. All rights reserved. Real CPR Help and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.
*References furnished upon request.
Source: ZOLL Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.